Tisento Therapeutics
PrivateLast Round
Series A
Jul 28, 2023
Est. Valuation
$100M
Total Funding Raised
$81M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Tisento Therapeutics is a biotechnology company developing novel medicines for the treatment of rare mitochondrial diseases, including Mitochondrial Encephalomyopathy with Lactic Acidosis and Stroke-like episodes (MELAS).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tisento Therapeutics Comparables
Compare Tisento Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pharming Group N.V. | 85% | |
| Khondrion | 84% | |
| Cyclerion Therapeutics | 80% | |
Tisento Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 28, 2023 |
Key People
Founding team and executive leadership
Tisento Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Invus Opportunities | Series A |
| Sanofi Ventures | Series A |
| J. Wood Capital Advisors | Series A |
| Venrock | Series A |
| Polaris Partners | Series A |
| Invus | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors increased 68% MoM.
- May 22, 2025
Presenting at the Reagan-Udall Foundation workshop on May 22, 2025.
Tisento Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tisento Therapeutics's valuation, stock price, and market status.